Panzara MA - Search Results

1

The polymerase chain reaction for detection of T-cell antigen receptor expression.

Panzara MA, Oksenberg JR, Steinman L. Panzara MA, et al. Curr Opin Immunol. 1992 Apr;4(2):205-10. doi: 10.1016/0952-7915(92)90015-7. Curr Opin Immunol. 1992. PMID: 1605910 Review.

2

Analysis of the T cell repertoire using the PCR and specific oligonucleotide primers.

Panzara MA, Gussoni E, Steinman L, Oksenberg JR. Panzara MA, et al. Biotechniques. 1992 May;12(5):728-35. Biotechniques. 1992. PMID: 1515141

3

Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis.

Oksenberg JR, Panzara MA, Begovich AB, Mitchell D, Erlich HA, Murray RS, Shimonkevitz R, Sherritt M, Rothbard J, Bernard CC, Steinman L. Oksenberg JR, et al. Among authors: panzara ma. Nature. 1993 Mar 4;362(6415):68-70. doi: 10.1038/362068a0. Nature. 1993. PMID: 7680433

4

Specific T cell receptor gene rearrangements at the site of muscle degeneration in Duchenne muscular dystrophy.

Gussoni E, Pavlath GK, Miller RG, Panzara MA, Powell M, Blau HM, Steinman L. Gussoni E, et al. Among authors: panzara ma. J Immunol. 1994 Nov 15;153(10):4798-805. J Immunol. 1994. PMID: 7963545

5

Multiple sclerosis: from immunogenetics to immunotherapy.

Oksenberg JR, Panzara MA, Steinman L. Oksenberg JR, et al. Among authors: panzara ma. J Neurol Sci. 1993 Apr;115 Suppl:S29-37. doi: 10.1016/0022-510x(93)90206-e. J Neurol Sci. 1993. PMID: 8340790 Review. No abstract available.

6

T cell receptor BV gene rearrangements in the spinal cords and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

Panzara MA, Gussoni E, Begovich AB, Murray RS, Zang YQ, Appel SH, Steinman L, Zhang J. Panzara MA, et al. Neurobiol Dis. 1999 Oct;6(5):392-405. doi: 10.1006/nbdi.1999.0252. Neurobiol Dis. 1999. PMID: 10527806

7

Evaluating human T cell receptor gene expression by PCR.

Gussoni E, Panzara MA, Steinman L. Gussoni E, et al. Among authors: panzara ma. Curr Protoc Immunol. 2001 May;Chapter 10:10.26.1-10.26.14. doi: 10.1002/0471142735.im1026s22. Curr Protoc Immunol. 2001. PMID: 18432691 Review.

8

Effect of natalizumab on conversion of gadolinium enhancing lesions to T1 hypointense lesions in relapsing multiple sclerosis.

Dalton CM, Miszkiel KA, Barker GJ, MacManus DG, Pepple TI, Panzara M, Yang M, Hulme A, O'Connor P, Miller DH. Dalton CM, et al. J Neurol. 2004 Apr;251(4):407-13. doi: 10.1007/s00415-004-0332-4. J Neurol. 2004. PMID: 15083284 Clinical Trial.

9

Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial.

Bar-Or A, Calabresi PA, Arnold D, Markowitz C, Shafer S, Kasper LH, Waubant E, Gazda S, Fox RJ, Panzara M, Sarkar N, Agarwal S, Smith CH. Bar-Or A, et al. Ann Neurol. 2008 Mar;63(3):395-400. doi: 10.1002/ana.21363. Ann Neurol. 2008. PMID: 18383069 Clinical Trial.

10

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, Bar-Or A, Panzara M, Sarkar N, Agarwal S, Langer-Gould A, Smith CH; HERMES Trial Group. Hauser SL, et al. N Engl J Med. 2008 Feb 14;358(7):676-88. doi: 10.1056/NEJMoa0706383. N Engl J Med. 2008. PMID: 18272891 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters